Presentation TCT 2016 Reimbursement Challenges For LAAC: Balancing The Clinical Need Vs. Robust Data Vs. Societal Economic Considerations Presenter: Aaron V. Kaplan, Rachel Neubrander, Tamara Syrek Jensen November 01, 2016
Presentation TCT 2016 Pivotal Trial Design Considerations: Noninferiority vs Superiority, Device, Control Arm Anticoagulation Durations, NOAC Considerations and More Industry and Clinician Perspectives Presenter: Aaron V. Kaplan, Rachel Neubrander, Brian K. Whisenant November 01, 2016
Presentation TCT 2016 Trial Designs For LAA Closure: Potential Regulatory Pathways and Unanswered Questions What FDA Would Like to See Presenter: Aaron V. Kaplan, Rachel Neubrander, Katherine Wallon November 01, 2016
Presentation TCT 2016 The Tricuspid Valve: Challenges for Clinical Investigation Presenter: Matthew G. Hillebrenner, Michael J. Mack, Rebecca T. Hahn November 01, 2016
Presentation TCT 2016 Learnings From A Pivotal Transcatheter Mitral Device Trial: Can The MVARC/COAPT Paradigm Be Shortened? Presenter: Matthew G. Hillebrenner, Michael J. Mack, Gregg W. Stone November 01, 2016
Presentation TCT 2016 Possible Approval Pathways for New Mitral and Tricuspid Valve Therapies Presenter: Matthew G. Hillebrenner, Michael J. Mack, John C Laschinger November 01, 2016
Presentation TCT 2016 Spectrum and Assessment of TAVR Accessory Devices (Valvuloplasty Balloons, Neuroprotection Systems, and More) Presenter: Nicole Ibrahim, Martin B. Leon November 01, 2016
Presentation TCT 2016 Valve Degeneration and Mobility Considerations: Assessing Clinical Relevance Presenter: Nicole Ibrahim, Martin B. Leon, Raj Makkar November 01, 2016
News Industry News TCT 2016 Long-Term Study Results Show that PFO Closure is More Effective Than Medical Management in Preventing Recurrent Stroke November 01, 2016
Presentation TCT 2016 FDA Perspectives on TAVR Label Expansion (E.G. Lower Risk Patients, Bicuspid Aortic Stenosis and Aortic Insufficiency), and New and Iterative Device Approval Pathways Presenter: Nicole Ibrahim, Martin B. Leon, Jaime Raben November 01, 2016
News Conference News TCT 2016 Final RESPECT Data Support PFO Closure for Cryptogenic Stroke Prevention Yael L. Maxwell November 01, 2016
News Industry News Study Finds Use Of Adjuctive Cerebral Embolic Protection During Transcatheter Aortic Valve Replacement Was Safe But Improvement In MRI Findings Did Not Reach Statistical Significance November 01, 2016
News Industry News Five Year Echocardiogram Follow-Up Data Demonstrates Sustained Durability After Transcatheter Aortic Valve Replacement In High-Risk And Inoperable Patients November 01, 2016
News Industry News TCT 2016 Patients With Sever Aortic Stenosis And Intermediate Surgical Risk Show Similar Late Quality of Life Outcomes Following Either Transcatheter or Surgical Aortic Valve Replacement November 01, 2016
Presentation TCT 2016 My Most Challenging Case 2016: Severe LV Dysfunction Presenter: Shao-Liang Chen, Ajay J. Kirtane, Manish A. Parikh, Bo Xu, Qi Zhang October 31, 2016
News Opinion Editor's Corner TCT 2016 TCT 2016: Inspiration and Perspiration Greet Left Main Stenting, Hoop Dreams, Valve Innovation, and Election Fever Shelley Wood October 24, 2016
News Daily News In Print at Last, Early Cardioband Results Show Safety, Feasibility at 6 Months Shelley Wood October 04, 2016
News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for September 2016 Shelley Wood September 30, 2016
News Conference News PCR London Valves 2016 Cerebral Protection in TAVR: New Insights, New Questions as First Device Seeks FDA Clearance Shelley Wood September 22, 2016
News Daily News Stroke Risk With TAVR: In-Depth Review of PARTNER and CoreValve Data Reveals Opportunities and Unknowns Shelley Wood September 13, 2016